All results

186 results for tests

• 1305-0014 (FIBRONEERTM IPF)

  This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they…

  Ages

  40 Years - N/A

  Sexes

  All

• ADOPT PGx

  This study is comprised of three separate pharmacogenetic trials grouped into a single protocol due to similarities in the intervention, the hypotheses, and…

  Ages

  8 Years - N/A

  Sexes

  All

• PD GENE

  Development of a central repository for PD-related genomic data for future research. The purpose of this study is to develop a central repository for…

  Ages

  18 Years - N/A

  Sexes

  All

• DISSECT-N

  DISSECT-N is a post-market registry designed to assess real-world safety and effectiveness of Valiant Navion Thoracic Stent Graft System in the treatment of…

  Ages

  18 Years - N/A

  Sexes

  All

• Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias

  Spinocerebellar ataxias (SCA) are genetic neurological diseases that cause imbalance, poor coordination, and speech difficulties. There are different kinds of…

  Ages

  6 Years - N/A

  Sexes

  All

• PK sensitivity in fluticasone propionate dry powder inhalers

  When a drug company first develops a drug, the company has to show the Food and Drug Administration (FDA) that the drug is safe and effective. If FDA concludes…

  Ages

  18 Years - 50 Years

  Sexes

  All

• BLUE-C

  The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test. Subjects 40 years of age…

  Ages

  40 Years - N/A

  Sexes

  All

• SENSE

  This study is a two-stage, pivotal, prospective, non-randomized, multi-center, within patient comparison of the SENSE device and the standard diagnostic test,…

  Ages

  22 Years - N/A

  Sexes

  All

• CardiAMP

  This is a prospective, multi-center, randomized, controlled, patient* and evaluator-blinded study comparing treatment with the CardiAMP cell therapy to a sham…

  Ages

  21 Years - 90 Years

  Sexes

  All

• GUARDD-US

  The primary aim is to determine the effect of participant and provider knowledge of a positive APOL1 status and accompanying guideline based clinical decision…

  Ages

  18 Years - 70 Years

  Sexes

  All